34 research outputs found
Spheroid Culture of Head and Neck Cancer Cells Reveals an Important Role of EGFR Signalling in Anchorage Independent Survival
In solid tumours millions of cells are shed into the blood circulation each
day. Only a subset of these circulating tumour cells (CTCs) survive, many of
them presumable because of their potential to form multi-cellular clusters
also named spheroids. Tumour cells within these spheroids are protected from
anoikis, which allows them to metastasize to distant organs or re-seed at the
primary site. We used spheroid cultures of head and neck squamous cell
carcinoma (HNSCC) cell lines as a model for such CTC clusters for determining
the role of the epidermal growth factor receptor (EGFR) in cluster formation
ability and cell survival after detachment from the extra-cellular matrix. The
HNSCC cell lines FaDu, SCC-9 and UT-SCC-9 (UT-SCC-9P) as well as its cetuximab
(CTX)-resistant sub-clone (UT-SCC-9R) were forced to grow in an anchorage-
independent manner by coating culture dishes with the anti-adhesive polymer
poly-2-hydroxyethylmethacrylate (poly-HEMA). The extent of apoptosis,
clonogenic survival and EGFR signalling under such culture conditions was
evaluated. The potential of spheroid formation in suspension culture was found
to be positively correlated with the proliferation rate of HNSCC cell lines as
well as their basal EGFR expression levels. CTX and gefitinib blocked, whereas
the addition of EGFR ligands promoted anchorage-independent cell survival and
spheroid formation. Increased spheroid formation and growth were associated
with persistent activation of EGFR and its downstream signalling component
(MAPK/ERK). Importantly, HNSCC cells derived from spheroid cultures retained
their clonogenic potential in the absence of cell-matrix contact. Addition of
CTX under these conditions strongly inhibited colony formation in CTX-
sensitive cell lines but not their resistant subclones. Altogether, EGFR
activation was identified as crucial factor for anchorage-independent survival
of HNSCC cells. Targeting EGFR in CTC cluster formation might represent an
attractive anti-metastatic treatment approach in HNSCC
Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities
Genetic investigation of tumor heterogeneity and clonal evolution in solid cancers could be assisted by the analysis of liquid biopsies. However, tumors of various entities might release different quantities of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) into the bloodstream, potentially limiting the diagnostic potential of liquid biopsy in distinct tumor histologies. Patients with advanced colorectal cancer (CRC), head and neck squamous cell carcinoma (HNSCC), and melanoma (MEL) were enrolled in the study, representing tumors with different metastatic patterns. Mutation profiles of cfDNA, CTCs, and tumor tissue were assessed by panel sequencing, targeting 327 cancer-related genes. In total, 30 tissue, 18 cfDNA, and 7 CTC samples from 18 patients were sequenced. Best concordance between the mutation profile of tissue and cfDNA was achieved in CRC and MEL, possibly due to the remarkable heterogeneity of HNSCC (63%, 55% and 11%, respectively). Concordance especially depended on the amount of cfDNA used for library preparation. While 21 of 27 (78%) tissue mutations were retrieved in high-input cfDNA samples (30-100 ng, N = 8), only 4 of 65 (6%) could be detected in low-input samples (<30 ng, N = 10). CTCs were detected in 13 of 18 patients (72%). However, downstream analysis was limited by poor DNA quality, allowing targeted sequencing of only seven CTC samples isolated from four patients. Only one CTC sample reflected the mutation profile of the respective tumor. Private mutations, which were detected in CTCs but not in tissue, suggested the presence of rare subclones. Our pilot study demonstrated superiority of cfDNA- compared to CTC-based mutation profiling. It was further shown that CTCs may serve as additional means to detect rare subclones possibly involved in treatment resistance. Both findings require validation in a larger patient cohort
Taxonomic review of the genus Stenotus Jakovlev (Hemiptera: Heteroptera: Miridae) from the Korean Peninsula
AbstractA genus Stenotus Jakovlev (Hemiptera: Heteroptera: Miridae) is reviewed taxonomically from the Korean Peninsula with a new record Stenotus binotatus (Fabricius 1794). Morphological information, such as descriptions of male and female genitalia, of the Korean species with photographs and illustrations, and a key to the Korean species are provided
Intratumor Heterogeneity in Epithelial Cancer: Assessment in Cell Line Models and Circulating Tumor Cells
Background: CTCs are present only in small numbers in patients' blood. This study aimed to establish a protocol for enumeration and phenotypic characterization of circulating tumor cells (CTCs) by ImageStreamX MK II (AMNIS) imaging flow cytometry and to characterize the expression of epithelial, mesenchymal, and stem cell markers in CTCs. Methods: The study used the FaDu cell line at different passages, cisplatin-resistant (FaDu CDDP-R), and irradiation-resistant (FaDu IR-R) subclones, as well as blood samples from head and neck squamous cell carcinoma (HNSCC) and colorectal cancer (CRC) patients for CTC detection (n = 5). Cells were fixed using 4% paraformaldehyde and permeabilized by incubation in 0.3% Triton X-100. The cell suspensions were stained with 1:100 EpCAM AF-488, 1:50 CD45 AF-647, 1:50 Vimentin AF-555, and 1:50 ALDH1A AF-594 antibodies. Results: There were significant differences in EpCAM expression levels between FaDu at late passage and FaDu CDDP-R subclones, as well as between FaDu at late passage compared with FaDu IR-R. Furthermore, CTCs were successfully detected in five patients' samples with various CTC subpopulations. Conclusions: Intratumor heterogeneity in CTC phenotypes existed in CRC and HNSCC. Furthermore, three main subpopulations of CTCs were detected. Our findings strongly support future phenotypic studies of CTCs
Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance
Effects of EGFR activation/blockade on spheroid volume.
<p>Cells were seeded at a density of 300,000 cells/well into poly-HEMA coated 6-well plates and treated with the indicated agents. After 72h, the diameters of at least 15 spheroids were measured and spheroid volumes calculated relative to the untreated spheroids. Bars represent mean values ± SD of four independent experiments. For the cell line SCC-9 the y-axis was adapted due to the EGF-induced strong increase in spheroid volumes.</p
CTX affects proliferation of spheroids in sensitive cell lines.
<p>MTT assays were performed in 96-well plates with cells treated with EGFR stimulating or blocking reagents in monolayer (M) or forced suspension (FS) culture. Bars represent mean percentages ± SD of four independent experiments. Significant changes compared to control are marked with an asterisk.</p
THAP1, the gene mutated in DYT6 dystonia, autoregulates its own expression.
THAP1 encodes a transcription factor but its regulation is largely elusive. TOR1A was shown to be repressed by THAP1 in vitro. Notably, mutations in both of these genes lead to dystonia (DYT6 or DYT1). Surprisingly, expressional changes of TOR1A in THAP1 mutation carriers have not been detected indicating additional levels of regulation. Here, we investigated whether THAP1 is able to autoregulate its own expression. Using in-silico prediction, luciferase reporter gene assays, and (quantitative) chromatin immunoprecipitation (ChIP), we defined the THAP1 minimal promoter to a 480bp-fragment and demonstrated specific binding of THAP1 to this region which resulted in repression of the THAP1 promoter. This autoregulation was disturbed by different DYT6-causing mutations. Two mutants (Ser6Phe, Arg13His) were shown to be less stable than wildtype THAP1 adding to the effect of reduced binding to the THAP1 promoter. Overexpressed THAP1 is preferably degraded through the proteasome. Notably, endogenous THAP1 expression was significantly reduced in cells overexpressing wildtype THAP1 as demonstrated by quantitative PCR. In contrast, higher THAP1 levels were detected in induced pluripotent stem cell (iPS)-derived neurons from THAP1 mutation carriers. Thus, we identified a feedback-loop in the regulation of THAP1 expression and demonstrated that mutant THAP1 leads to higher THAP1 expression levels. This compensatory autoregulation may contribute to the mean age at onset in the late teen years or even reduced penetrance in some THAP1 mutation carriers
EGFR signalling regulates clonogenic survival of HNSCC cells derived from forced suspension cultures.
<p>Cells were cultured as monolayer (M) or in forced suspension (FS) in the absence or presence of EGF, AREG or CTX. 72h later, cells were harvested, disaggregated to single cells and subjected to clonogenic survival analysis. Bars represent the surviving fractions (SF) ± SD from three independent experiments. Significant changes compared to control are marked with an asterisk.</p
Hidden Mutations in CdLS - Limitations of Sanger Sequencing in Molecular Diagnostics
International audienceCornelia de Lange syndrome (CdLS) is a well characterized developmental disorder. The genetic cause of CdLS is a mutation in one of five associated genes (NIPBL, SMC1A, SMC3, RAD21 and HDAC8) accounting for about 70 % of cases. To improve our current molecular diagnostic and to analyze some of CdLS candidate genes we developed and established a gene panel approach. Because recent data indicate a high frequency of mosaic NIPBL mutations that were not detected by conventional sequencing approaches of blood DNA, we started to collected buccal mucosa samples of our patients that were negative for mutations in the known CdLS genes. Here we report the identification of three mosaic NIPBL mutations by our high-coverage gene panel sequencing approach that were undetected by classical Sanger sequencing analysis of buccal mucosa DNA. All mutations were confirmed by the use of highly sensitive SNaPshot fragment analysis using DNA from buccal mucosa, urine and fibroblast samples. In blood samples we could not detect the respective mutation. Finally, in fibroblast samples from all three patients, Sanger sequencing could identify all the mutations. Thus, our study highlights the need for highly sensitive technologies in molecular diagnostic of CdLS to improve genetic diagnosis and counseling of patients and their families. This article is protected by copyright. All rights reserved